The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

Micron Biomedical today announced the grand opening of its world-class manufacturing facility spanning more than 26,000 ...

Move over karyotypes—genetic disorder detection has vastly improved. Researchers are now using array CGH (aCGH), to quickly scan through an entire genome for imbalances. Because aCGH facilitates ...

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...

One of the challenges for the future is how to integrate all the DNA microarray data that have been generated and deposited in public databases. We have studied data from two data repositories and ...

Genomic assays have become indispensable tools in the management of early-stage invasive breast cancer, helping oncologists ...

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of ...

Scientists analyzing the genomes of thousands of people across Japan discovered evidence for a previously overlooked third ...

A major genetic analysis of over 3,200 Japanese individuals reveals a more complex ancestry than previously thought, ...

Researchers have created an innovative paper-based analytical device that can detect microRNA-21—a biomarker associated with ...

U.S. Genomic Medicine Market was valued at USD 9.93 billion in 2025 and is expected to reach USD 32.9 billion by 2035 owing to the increasing use of personalized medicineAustin, May 14, 2026 (GLOBE ...

Pregnancy care is now being transformed from its traditional, observational monitoring approach into a proactive, precision-led process, thanks to antenatal genomics.